Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Supernus Pharmaceuticals 

1550 East Gude Drive

Rockville  Maryland  20850  U.S.A.
Phone: 301-838-2501 Fax: n/a


 Key Statistics

Ownership: Public

Web Site: Supernus Pharmaceuticals
Symbol: SUPN


 Company News
Supernus Pharmaceuticals (SUPN) To Present At March Cowen and Company Conference 2/19/2015 8:45:23 AM
Supernus Pharmaceuticals (SUPN) To Host Fourth Quarter And Full Year 2014 Earnings Conference Call 2/18/2015 7:45:47 AM
Supernus Pharmaceuticals (SUPN) Sues TWi Pharmaceuticals, Inc. For Infringement Of Oxtellar XR® Patents 1/22/2015 8:14:41 AM
Supernus Pharmaceuticals (SUPN) Sues Par Pharmaceutical Companies, Inc. (PRX) For Infringement Of Trokendi XR® Patents 1/19/2015 7:05:30 AM
Supernus Pharmaceuticals (SUPN) Announces Paragraph IV ANDA Filing for Oxtellar XR® 12/10/2014 7:06:46 AM
Supernus Pharmaceuticals (SUPN) Announces Paragraph IV ANDA Filing for Trokendi XR® 12/9/2014 10:54:54 AM
Supernus Pharmaceuticals (SUPN) Files Lawsuit Against Zydus Pharmaceuticals (USA) Inc. In U.S. Court For Infringement Of Patents Covering Its Antiepileptic Drug, Trokendi XR 11/25/2014 7:18:12 AM
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Fifth U.S. Patent Protecting Trokendi XR(R) 11/24/2014 1:12:06 PM
Supernus Pharmaceuticals (SUPN) Sues Zydus Pharmaceuticals (USA) Inc. For Infringement Of Trokendi XR(R) Patents 11/24/2014 12:53:42 PM
Supernus Pharmaceuticals (SUPN) Announces Third Quarter 2014 Results 11/12/2014 7:54:47 AM